HKEX: 6955
Interim report 2026
View original source (HKEXnews)
Earlier from Shandong Boan Biotechnology Company., Limited. Class H
- Poll results of the annual general meeting held on 22 june 2026
- Voluntary announcement licensing of dulaglutide injection in the U.S.
